CHI Memorial follows the National Comprehensive Cancer Network (NCCN) guidelines for the diagnosis and treatment of prostate cancer. Widely recognized and used as the gold standard by oncologists and other medical professionals, their recommendations are based on treatment plans of healthcare providers worldwide, the latest research and years of experience.
Prostate cancer is typically slow-growing and, if caught in the early stages, has a high rate of cure. Once identified, prostate cancers can be treated with hormones, radiation, surgeries (including new minimally invasive robotic assisted options) and, in rare cases, chemotherapy. At CHI Memorial, specialists in many disciplines come together in regularly scheduled cancer conferences and use their expertise to recommend a course of treatment.
When you seek treatment at CHI Memorial, you can feel confident that the treatment plan recommended is not based on the opinion of a few, but on the analysis of a much broader medical community focused on eliminating cancer using the most advanced treatment strategies. That research, combined with our cancer specialists’ expertise, means they can individualize treatment and you have a framework that makes your options clearer and offers greater peace of mind.
Click here for a comprehensive overview of the NCCN 2020 Prostate Cancer Early Stage Guidelines. Inside you’ll find screening options, symptoms and stages of the disease, managing risk factors, treatment for early and later stage prostate cancer, and life after cancer treatment.